Medicine
Pilocarpine 7.5 mg tablet
Pilocarpine 7.5 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store up to 25°C (77°F), excursions permitted to 15°-30°C (59°-86°F).
Key facts
- Active ingredient (INN)
- Pilocarpine
- Brand
- Sold under the generic name
- Strength
- 7.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets
- Manufacturers
- Aurobindo PharmaIndiaActavis PharmaLannett
- Origin register
- US FDA, United States
- Storage
- Store up to 25°C (77°F), excursions permitted to 15°-30°C (59°-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07AX01 Pilocarpine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 October 2005
- Identifiers
- RxCUI 1000913, 1001004DailyMed set ID 610022b7-7dc9-405a-a580-104657f43bdf, 438cfaa3-b5f6-4d75-ac22-b0b4e07bb118, 8db0db4f-55ad-46b2-af50-e71b4a763aaaNDC 0228-2837, 59651-225, 0527-1407Application NDA020237, ANDA212377, ANDA077220
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 59651-225-01 | Aurobindo PharmaIndia | 13 August 2019 |
| 100 tablet, film coated in 1 bottle, plastic | 0228-2837-11 | Actavis Pharma | 13 September 2011 |
| 100 tablet, film coated in 1 bottle | 0527-1407-01 | Lannett | 14 October 2005 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 July 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Pilocarpine 7.5 mg tablet.
Other strengths and forms of Pilocarpine
Clinical summary
Pilocarpine is a cholinergic receptor agonist. It is available as tablets, eye drops and ophthalmic solution for oral use. MedsAcross supplies Pilocarpine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PilocarpineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Salagen prescribing information (Advanz Pharma) · U.S. National Library of Medicine, DailyMed
Need Pilocarpine 7.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.